Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (Q1)Dec 31, 2025 | (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2,337.19%-253.35K | 14.60%-1.11M | -28.18%-363.81K | -82.90%-609.5K | 11.26%-126.64K | 98.08%-10.4K | -251.55%-1.3M | -182.82%-283.82K | -682.12%-333.23K | 17.48%-142.71K |
| Net income from continuing operations | 103.24%4.52K | 80.03%-405.62K | 161.00%163.39K | 66.64%-208.15K | 77.08%-221.24K | 19.98%-139.62K | -155.51%-2.03M | 42.08%-267.86K | -423.70%-623.95K | -1,474.41%-965.12K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | -128.70%-8.63K | --0 | ---- | ---- |
| Asset impairment expenditure | ---- | -101.45%-10.41K | -280.45%-10.41K | --0 | ---- | ---- | 87.97%717.38K | -100.72%-2.74K | --32.43K | ---- |
| Unrealized gains and losses of investment securities | ---- | --0 | --0 | --0 | --0 | --0 | 90.26%-7.5K | --0 | 15.01%4.31K | 100.28%187 |
| Remuneration paid in stock | --0 | -82.67%58.37K | --0 | -99.98%61 | --51.08K | --7.23K | --336.74K | --50.56K | --286.18K | --0 |
| Other non cashItems | -215.68%-259.25K | -812.48%-509.06K | -17.28%-401.06K | ---19.24K | ---6.64K | ---82.12K | 66.03%-55.79K | -157.10%-341.97K | ---- | ---- |
| Change In working capital | -99.32%1.38K | 2.95%-243.62K | -1,348.37%-115.73K | -1,520.68%-382.17K | -62.72%50.16K | 157.66%204.12K | -198.55%-251.02K | -107.28%-7.99K | -132.40%-23.58K | 985.89%134.54K |
| -Change in receivables | -8.02%9.75K | -75.16%-37.29K | -138.54%-59.46K | -22.68%1.96K | -36.15%9.61K | 176.04%10.61K | -132.41%-21.29K | -223.43%-24.93K | -90.81%2.53K | 224.60%15.06K |
| -Change in prepaid assets | -63.63%10.48K | -170.06%-111.2K | -141.38%-36.23K | -122.41%-23.13K | -192.69%-80.67K | 109.04%28.83K | -157.06%-41.18K | 613.80%87.55K | 877.24%103.19K | 389.94%87.04K |
| -Change in payables and accrued expense | -111.45%-18.86K | 49.55%-95.13K | 71.63%-20.03K | -179.20%-361.01K | 273.58%121.22K | 880.85%164.69K | -153.73%-188.55K | -129.04%-70.61K | -391.59%-129.3K | 559.60%32.45K |
| -Change in other current liabilities | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2,337.19%-253.35K | 14.60%-1.11M | -28.18%-363.81K | -82.90%-609.5K | 11.26%-126.64K | 98.08%-10.4K | -251.55%-1.3M | -182.82%-283.82K | -682.12%-333.23K | 17.48%-142.71K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -126.52%-1.16M | -331.53%-1.48M | -352.73%-902.7K | -20.34%-76.42K | 199.42%9.29K | -620.25%-511.2K | -53.02%-343.21K | -2,859.36%-199.39K | -509.69%-63.5K | -105.51%-9.34K |
| Net PPE purchase and sale | -129.25%-1.17M | -318.57%-1.55M | -340.53%-902.37K | 9.77%-75.91K | -501.62%-56.19K | -620.25%-511.2K | 18.44%-369.27K | -2,936.66%-204.84K | -707.10%-84.12K | -215.35%-9.34K |
| Net investment purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | -90.46%20.63K | --0 | --20.63K | --0 |
| Net other investing changes | --13.95K | 1,087.36%64.64K | ---329 | ---508 | ---- | ---- | -55.46%5.44K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -126.52%-1.16M | -331.53%-1.48M | -352.73%-902.7K | -20.34%-76.42K | 199.42%9.29K | -620.25%-511.2K | -53.02%-343.21K | -2,859.36%-199.39K | -509.69%-63.5K | -105.51%-9.34K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 30,905.76%2.16M | 69.29%3.76M | 3,842.71%2.52M | -14.68%1.07M | 1,758.00%168K | -100.79%-7K | 1,975.28%2.22M | -24.71%64K | 1.26M | -58.83%9.04K |
| Net common stock issuance | --2.25M | 59.68%3.82M | 2,527.71%2.47M | -14.35%1.17M | 1,086.67%178K | --0 | --2.39M | --94K | --1.37M | --15K |
| Proceeds from stock option exercised by employees | --109.7K | --192.95K | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | -2,811.39%-203.8K | -47.78%-255K | -365.66%-139.7K | 28.34%-78.8K | -395.13%-29.5K | 73.71%-7K | -303.01%-172.56K | ---30K | ---109.97K | ---5.96K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 30,905.76%2.16M | 69.29%3.76M | 3,842.71%2.52M | -13.13%1.09M | 1,542.34%148.5K | -100.79%-7K | 1,975.28%2.22M | -24.71%64K | --1.26M | -58.83%9.04K |
| Net cash flow | ||||||||||
| Beginning cash position | 157.60%1.83M | 424.88%709.65K | -49.31%573.24K | -23.35%206.38K | -55.02%185.38K | 424.88%709.65K | -78.78%135.2K | 687.05%1.13M | 36.66%269.25K | 123.18%412.13K |
| Current changes in cash | 240.96%745.11K | 102.40%1.17M | 399.80%1.26M | -52.73%407.29K | 121.78%31.15K | -290.88%-528.59K | 218.31%576.39K | -5,057.64%-419.21K | 1,725.17%861.68K | -874.25%-143K |
| Effect of exchange rate changes | -143.92%-1.9K | -2,382.96%-48.22K | 1.11%-1.96K | -46,367.82%-40.43K | -8,356.10%-10.16K | 61,700.00%4.33K | 86.87%-1.94K | -465.53%-1.99K | 72.90%-87 | 102.01%123 |
| End cash Position | 1,287.01%2.57M | 157.60%1.83M | 157.60%1.83M | -49.31%573.24K | -23.35%206.38K | -55.02%185.38K | 424.88%709.65K | 424.88%709.65K | 687.05%1.13M | 36.66%269.25K |
| Free cash from | -173.25%-1.43M | -59.09%-2.66M | -159.11%-1.27M | -64.23%-685.4K | -20.25%-182.83K | 14.70%-521.59K | -102.95%-1.67M | -424.69%-488.66K | -687.03%-417.36K | 7.76%-152.05K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.